Folgen
Paul William Finn
Paul William Finn
Oxford Drug Design Limited, University of Buckingham, Affinity Drug Design
Bestätigte E-Mail-Adresse bei oxforddrugdesign.com
Titel
Zitiert von
Zitiert von
Jahr
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
N Khan, M Jeffers, S Kumar, C Hackett, F Boldog, N Khramtsov, X Qian, ...
Biochemical Journal 409 (2), 581-589, 2008
8742008
Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101
JA Plumb, PW Finn, RJ Williams, MJ Bandara, MR Romero, CJ Watkins, ...
Molecular cancer therapeutics 2 (8), 721-728, 2003
4582003
Quantitative proteomic analysis of post-translational modifications of human histones
HC Beck, EC Nielsen, R Matthiesen, LH Jensen, M Sehested, P Finn, ...
Molecular & Cellular Proteomics 5 (7), 1314-1325, 2006
2402006
Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo
N Steele, P Finn, R Brown, JA Plumb
British journal of cancer 100 (5), 758-763, 2009
1922009
Pharmacophore discovery using the inductive logic programming system Progol
P Finn, S Muggleton, D Page, A Srinivasan
Machine Learning 30, 241-270, 1998
1721998
Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
A Amolins, V Andrianov, RM Bokaldere, K Dikovska, JES Duffy, PW Finn, ...
US Patent 7,880,020, 2011
124*2011
ElectroShape: fast molecular similarity calculations incorporating shape, chirality and electrostatics
MS Armstrong, GM Morris, PW Finn, R Sharma, L Moretti, RI Cooper, ...
Journal of computer-aided molecular design 24, 789-801, 2010
1202010
Carbamic acid compounds comprising an amide linkage as hdac inhibitors
A Amolins, V Andrianov, RM Bokaldere, K Dikovska, JES Duffy, PW Finn, ...
US Patent App. 12/983,971, 2011
112*2011
Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
A Amolins, V Andrianov, RM Bokaldere, K Dikovska, JES Duffy, PW Finn, ...
US Patent 7,569,724, 2009
110*2009
Ultrafast shape recognition: evaluating a new ligand-based virtual screening technology
PJ Ballester, PW Finn, WG Richards
Journal of Molecular Graphics and Modelling 27 (7), 836-845, 2009
992009
Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
CJ Watkins, MR Romero-Martin, KG Moore, J Ritchie, PW Finn, I Kalvinsh, ...
US Patent 6,888,027, 2005
982005
RAPID: Randomized pharmacophore identification for drug design
PW Finn, LE Kavraki, JC Latombe, M R, C Shelton, ...
Computational Geometry: Theory and Applications 4 (10), 263-272, 1998
961998
The cell cycle, chromatin and cancer: mechanism-based therapeutics come of age
F McLaughlin, P Finn, NB La Thangue
Drug discovery today 8 (17), 793-802, 2003
892003
Carbamic acid compounds comprising an ether linkage as HDAC inhibitors
RM Bokaldere, JES Duffy, PW Finn, CJ Harris, I Kalvinsh, D Lolya, E Loza, ...
US Patent 6,960,685, 2005
83*2005
Computational approaches to drug design
PW Finn, LE Kavraki
Algorithmica 25, 347-371, 1999
831999
Novel sulfonamide derivatives as inhibitors of histone deacetylase
PW Finn, M Bandara, C Butcher, A Finn, R Hollinshead, N Khan, N Law, ...
Helvetica Chimica Acta 88 (7), 1630-1657, 2005
762005
Plasmodium subtilisin-like protease 1 (SUB1): insights into the active-site structure, specificity and function of a pan-malaria drug target
C Withers-Martinez, C Suarez, S Fulle, S Kher, M Penzo, JP Ebejer, ...
International journal for parasitology 42 (6), 597-612, 2012
702012
A randomized kinematics‐based approach to pharmacophore‐constrained conformational search and database screening
SM LaValle, PW Finn, LE Kavraki, JC Latombe
Journal of Computational Chemistry 21 (9), 731-747, 2000
622000
Improving the accuracy of ultrafast ligand-based screening: incorporating lipophilicity into ElectroShape as an extra dimension
MS Armstrong, PW Finn, GM Morris, WG Richards
Journal of computer-aided molecular design 25, 785-790, 2011
602011
Are the physicochemical properties of antibacterial compounds really different from other drugs?
JP Ebejer, MH Charlton, PW Finn
Journal of cheminformatics 8, 1-9, 2016
592016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20